Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid...

by D Kyburz, C Gabay, A Finckh, C Tellenbach, L Herzog, A Scherer, B Moeller, A Ciurea, I von Muehlenen, L Brulhart, R Müller, P Hasler, P Zufferey
Published 2020-05-01

Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study

by D.S. Courvoisier, D. Alpizar-Rodriguez, J.E. Gottenberg, M.V. Hernandez, F. Iannone, E. Lie, M.J. Santos, K. Pavelka, C. Turesson, X. Mariette, D. Choquette, M.L. Hetland, A. Finckh
Published 2016-09-01